EU Case Reports
[...] Sandoz submitted that the skilled team would know that, in the course of submitting an application for regulatory approval for a calcipotriol aqueous suspension cream, it could expect to be required by the regulatory authority to check whether the Active Pharmaceutical Ingredient (API) formed...
Saved in:
Published in | Journal of generic medicines Vol. 7; no. 2; pp. 195 - 203 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.04.2010
Sage Publications Ltd |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | [...] Sandoz submitted that the skilled team would know that, in the course of submitting an application for regulatory approval for a calcipotriol aqueous suspension cream, it could expect to be required by the regulatory authority to check whether the Active Pharmaceutical Ingredient (API) formed a hydrate. [...] the skilled team would be bound to check for the presence of hydrates in any event, in the course of routine stability studies. |
---|---|
ISSN: | 1741-1343 1741-7090 |
DOI: | 10.1057/jgm.2010.9 |